CA2510289A1 — Pharmaceutical compositions and method of treating parkinson's disease
Assigned to Merck Frosst Canada and Co · Expires 2004-07-15 · 22y expired
What this patent protects
This invention is directed to the use of certain pharmaceutical compositions for treating and methods of treating Parkinson s disease. In particular, thi s invention is directed to pharmaceutical compositions for treating and method s of treating Parkinson s disease comprising th…
USPTO Abstract
This invention is directed to the use of certain pharmaceutical compositions for treating and methods of treating Parkinson s disease. In particular, thi s invention is directed to pharmaceutical compositions for treating and method s of treating Parkinson s disease comprising the use of selective cyclooxygena se- 2 inhibitors, such as rofecoxib, etoricoxib, celecoxib and valdecoxib, with and without concomitant use of one or more antiparkinson drugs.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.